COVID-19: Therapeutics and interventions currently under consideration

RB McFee - Disease-a-Month, 2020 - Elsevier
With the emergence of COVID-19 extensive research began to identify medications,
candidate compounds and other therapeutic approaches. The complex virology of COVID …

[HTML][HTML] COVID-19: before the fall, an evidence-based narrative review of treatment options

N Rebold, D Holger, S Alosaimy, T Morrisette… - Infectious Diseases and …, 2021 - Springer
Abstract The 2019 novel coronavirus (COVID-19) has quickly become one of the most dire
international pandemic crises since the 1918 Spanish flu. Evidence for COVID-19 …

[HTML][HTML] Pharmacologicaltreatment of COVID-19: lights and shadows

F Menzella, M Biava, C Barbieri, F Livrieri… - Drugs in …, 2020 - ncbi.nlm.nih.gov
At the end of December 2019, a novel coronavirus, the severe acute respiratory syndrome
coronavirus 2, caused an outbreak of pneumonia spreading from Wuhan, Hubei province, to …

Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review

JM Sanders, ML Monogue, TZ Jodlowski, JB Cutrell - Jama, 2020 - jamanetwork.com
Importance The pandemic of coronavirus disease 2019 (COVID-19) caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an …

[PDF][PDF] A contemporary look at COVID-19 medications: available and potentially effective drugs

HK Alshaeri, ZS Natto - Eur Rev Med Pharmacol Sci, 2020 - researchgate.net
OBJECTIVE: There have been significant changes to the management of COVID-19 in
recent months, including protocols and guidelines designed to prevent, diagnose, and treat …

[HTML][HTML] Recent advances in management of COVID-19: A review

S Mouffak, Q Shubbar, E Saleh, R El-Awady - Biomedicine & …, 2021 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused and is still causing
significant mortality and economic consequences all over the globe. As of today, there are …

Treatment considerations for COVID-19: a critical review of the evidence (or lack thereof)

P Vijayvargiya, ZE Garrigos, NEC Almeida… - Mayo Clinic …, 2020 - Elsevier
The novel severe acute respiratory syndrome coronavirus 2 is causing a worldwide
pandemic that may lead to a highly morbid and potentially fatal coronavirus disease 2019 …

[HTML][HTML] An update on current therapeutic drugs treating COVID-19

R Wu, L Wang, HCD Kuo, A Shannar, R Peter… - Current pharmacology …, 2020 - Springer
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …

[HTML][HTML] Potential therapeutic options for COVID-19: current status, challenges, and future perspectives

C Sarkar, M Mondal, M Torequl Islam… - Frontiers in …, 2020 - frontiersin.org
The COVID-19 pandemic represents an unprecedented challenge for the researchers to
offer safe, tolerable, and effective treatment strategies for its causative agent known as …

[HTML][HTML] Current status of COVID-19 treatment: An opinion review

S Di Franco, A Alfieri, S Petrou, G Damiani… - World journal of …, 2020 - ncbi.nlm.nih.gov
The pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
has garnered the attention of scientists worldwide in the search for an effective treatment …